2018

In May 2018, the United States Food and Drug Administration (FDA) issued two draft guidance documents focused on developing a…

Following on the heels of more than 40 state legislatures, the U.S. Congress passed a federal right-to-try law giving patients…

On August 6, 2018, the United States Food and Drug Administration (FDA) released draft guidance, Opioid Use Disorder: Endpoints…

As telemedicine continues to grow, it is likely to have impacts in all facets of the healthcare industry. BDO USA, LLP recently…

In 1993, Minnesota became the first state to limit gifts and compensation provided by life science companies to healthcare…

As reported by Regulatory Focus, Biosimilar experts from across the EU continue to show how rapidly biosimilars have gained market…

In July 2018, medical device manufacturer AngioDynamics, Inc., agreed to pay the United States $12.5 million to resolve…

In a report released by the American Medical Association (AMA) , it was found that nationwide, more than 19 million fewer…

This is the second article in the series exploring the major themes emerging from recent efforts to combat the ‘opioid crisis’ and…

A federal judge recently denied motions by Humana Inc., in an ongoing whistleblower lawsuit with Hoffman-LaRoche Ltd. The lawsuit…